Julie Jordan - Chief Medical Officer at Q32 Bio Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Julie Jordan since 25 Jul 2025

Reported holdings for Julie Jordan in Q32 Bio Inc.

Form 4 holding Chief Medical Officer

Homology Medicines, Inc.

Security class
Common Stock
Shares / value
7,496
Estimated value
$4,243
Report date
03 Aug 2023
Price
$0.5660
Ownership
Direct
Form 4 holding Chief Medical Officer

Homology Medicines, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
03 Aug 2023
Price
$1.15
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Julie Jordan in Q32 Bio Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .